Skip to content

Clinical trials

Phase 3 Fibrosis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Phase: Phase 3 Country / region: United Kingdom Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20092
20122
20143
20152
20161
20171
20181
20211
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting3
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences3
89bio, Inc.2
AbbVie2
King's College London2
Vertex Pharmaceuticals Incorporated2
Bristol-Myers Squibb1
Genfit1
Intercept Pharmaceuticals1
Inventiva Pharma1
Janssen-Cilag International NV1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis20
Hepatitis C6
Non-alcoholic Fatty Liver Disease5
Digestive System Diseases3
Hepatitis C, Chronic3
Liver Cirrhosis3
Liver Diseases3
Cystic Fibrosis2
Fatty Liver2
Genetic Diseases, Inborn2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.